相关实验视频

Updated: Apr 10, 2026

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

优化和表征N-乙胺作为针对PfATP4的抗疟疾药物

Jon Kyle Awalt^1,2, Zi Kang Ooi¹, Trent D Ashton^1,2

¹The Walter and Eliza Hall Institute of Medical Research, Parkville 3052, Australia.

Journal of medicinal chemistry

|April 14, 2025

概括

研究人员发现了针对Plasmodium falciparum ATP4.4的新型N-乙胺醇抗疟疾药物. 虽然WJM664具有强效和阻断传播,但在小鼠模型中显示出有限的疗效,需要进一步优化治疗开发.

科学领域:

药用化学医学化学
寄生虫学的寄生虫学
药物发现药物发现药物发现

背景情况:

疟疾仍然是一个重大的全球卫生挑战,需要开发新的抗疟疾药物.
识别新药标和化学支架对于克服耐药性至关重要.

研究的目的:

识别和优化针对Plasmodium falciparum的新型抗疟疾化合物.
验证PfATP4作为治疗疟疾的药物标.

主要方法:

在Janssen Jumpstarter图书馆进行高吞吐量选,以对抗Plasmodium falciparum.
结构-活动关系研究和优化.
耐药选择,全基因组测序和目标验证试验 (代谢学,ATPase活性).

主要成果:

确定N-乙胺英多尔作为一种新型抗疟疾药物.
优化的模拟WJM664显示出强大的无性阶段活性和代谢稳定性.
验证了pfATP4作为目标,WJM664显示对抗耐药菌株的功效降低,并抑制Na+依赖ATPase活性.
WJM664抑制了寄生虫的传播,但由于特定物种的ATP4差异和暴露,在Plasmodium berghei小鼠模型中显示出低效.

结论:

N-乙胺英多尔是针对PfATP4.4的抗疟疾药物开发的一个有前途的化学型.
需要进一步优化,以提高体内疗效,并解决治疗疗法和阻断传播疗法的特定物种向变异.

更多相关视频

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

相关概念视频

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...